Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
acetic acid (vosol) (1 trial)
fludeoxyglucose f-18 (1 trial)
ranolazine (ranexa) (1 trial)
Hypertension (Phase 2)
Hypertension, Pulmonary (Phase 2)
Trials (2 total)
Trial APIs (3 total)